Bristol Myers Squibb signs $15.2B licensing deal with Hengrui

🌐 qz.com —
Bristol Myers Squibb signs $15.2B licensing deal with Hengrui

AI Summary

Bristol Myers Squibb has entered into a $15.2 billion licensing agreement with Hengrui. This strategic deal is expected to enhance their market position and strengthen their portfolio.

Markets Deals Bristol Myers Squibb Hengrui licensing deal pharmaceuticals finance

Read original source →